P. Serafini

Immunology · 2002–2008

A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 83 citations into it; #564 of 2,160 by trust here, #408 by citations

Whom P. Serafini trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Gabrilovich
2. V. Bronte
3. P. Rodriguez
4. W. Zou
5. C. Bogdan

Who trusts P. Serafini overall

1. D. Gabrilovich
2. M. Munder
3. Ilaria Marigo
4. S. Ostrand-Rosenberg
5. P. Rodriguez
6. P. Sinha
7. V. Bronte
8. A. Sica
9. T. Condamine
10. Augusto Ochoa

Papers from P. Serafini's perspective

Ordered by how strongly the researchers P. Serafini trusts endorse each paper. Same corpus, a different order for every researcher.

1. Immunosuppressive networks in the tumour environment and their therapeutic relevance (Nature Reviews. Cancer)
2. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Journal of Clinical Investigation)
3. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (Journal of Immunology)
4. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (Journal of Experimental Medicine)
5. Altered macrophage differentiation and immune dysfunction in tumor development. (Journal of Clinical Investigation)
6. Immunosuppressive strategies that are mediated by tumor cells. (Annual Review of Immunology)
7. Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
8. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
9. NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway (Nature Immunology)
10. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. (New England Journal of Medicine)

Their papers

• Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (2006) — 770 citations
• Myeloid derived suppressor cells promote cross-tolerance in B cell lymphoma by expanding regulatory T cells (2008) — 688 citations
• Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells (2008) — 624 citations
• Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. (2006) — 897 citations
• Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. (2006) — 826 citations
• L-arginine metabolism in myeloid cells controls T-lymphocyte functions. (2003) — 619 citations
• Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (2002) — 741 citations